Cellular and gene therapy fields are currently on track for a serious capacity crunch.

Manufacturing Capacity Crunch

Best practices for scaling up manufacturing under a short deadline.

Scaling Up Fast

Flexible, adaptable processes speed the manufacture of investigational drug products.

Accelerating Clinical Trial Materials

Contract service companies fill voids in development and manufacturing.

Support During a Pandemic

Topic

Jared Auclair is associate dean, Professional Programs and Graduate Affairs, and director, Biopharmaceutical Analysis Training Lab, Northeastern University.

Lori Stansberry is marketing manager, Pharma & BioPharma, Thermo Fisher Scientific.

Articles

Vendors are finding ways to address the increasingly complex analytical challenges in the biopharmaceutical industry to further biotherapeutic development.

Is Collaboration the Key to Accelerating Biotherapeutic Development?

Rita Peters is editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.

Biopharma looks to deliver on COVID-19 vaccines and other promising therapies.

Bringing Bio/Pharma’s “New Normal” Into Focus

Essential bio/pharma employees show hard work and dedication can pay off for patients.

Compensation Does Not Necessarily Align With Job Satisfaction

Editor of Pharmaceutical Technology Europe

The right partner can help companies overcome key formulation challenges for biologic drugs.

Overcoming Biologic Drug Formulation Hurdles

Feliza Mirasol is the science editor for 

Traditional biologic-based testing methods may need an upgrade to properly test newer therapeutic modalities.

Meeting Specificity Needs for Biologic Drug Substance Testing

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Outsourcing increases as the industry balances development and manufacturing of both COVID-19 treatments and non-pandemic-related medicines.

Supporting the Industry During a Pandemic

The virtual manufacturer and distributor of specialty materials acquired the NY-based company, adding analytical and manufacturing expertise.

Aceto Acquires IsleChem

The UK company is investing £3 million in new instrumentation and equipment to strengthen its high-throughput screening and translational oncology service offerings.

Sygnature Discovery Expands High-Throughput Screening and Translational Oncology 

Evonik offers lipid nanoparticles for gene-based drug development and manufacturing. 

Evonik Supplies Key LNP Technology for Gene-Based Drugs

The company is investing in expansion at four sites in the United States, United Kingdom, and Italy, which will include construction of new facilities and addition of sterile and lyophilized filling lines.